Skip to main content
Interactive Cardiovascular and Thoracic Surgery logoLink to Interactive Cardiovascular and Thoracic Surgery
. 2013 Feb;16(2):156. doi: 10.1093/icvts/ivs527

eComment. The modifed maze procedure as concomitant surgery: the impact of left atrial size

Bachar El Oumeiri 1, Frederic Vanden eynden 1, Guido Van Nooten 1
PMCID: PMC3548548  PMID: 23334738

I read with great interest the paper by Bakker et al [1]. The Cox-maze III procedure achieved high curative rates and has become the surgical gold standard for the treatment of atrial fibrillation (AF). There are multiple risk factors for recurrent AF after a Cox-maze procedure: age, ejection fraction, duration of preoperative AF, surgical techniques, mitral valve disease, and left atrial size. The authors reported risk factors of recurrent AF but did not mention left atrial size. Duration of preoperative AF, age and ejection fraction were identified as risk factors for recurrent AF in several studies [1-3], but this is not all [4].

To our knowledge, there have been no studies denouncing the effect of left atrial size on the recurrence of AF. Increasing left atrial size was a significant risk factor for failure after a Cox-maze procedure [3,4]. Romano et al. [5] have demonstrated that combining atrial reduction plasty for a left atrial size >60 mm with a Cox-maze III procedure resulted in 89% of patients being in sinus rhythm at a mean follow-up of 19 months. Damiano et al. [4] suggest performing a more aggressive left atrial reduction or a more extensive ablation lesion set in patient with left atria ≤70 mm. We believe that in groups of patients with large left atria, the risk of recurence of AF should be strongly considered, and in this group, the value of concomitant atrial fibrillation ablation remains unclear. Surgeons must be careful for not increase the operative risk by adding a concomitant procedure of AF ablation.

Conflict of interest: none declared

References

  • 1.Bakker RC, Akin S, Rizopoulos D, Kik C, Takkenberg JJ, Bogers AJ. Results of clinical application of the modified maze procedure as concomitant surgery. Interact CardioVasc Thorac Surg. 2012 doi: 10.1093/icvts/ivs440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gaynor SL, Schuessler RB, Bailey MS, Ishii Y, Boineau JP, Gleva MJ, et al. Surgical treatment of atrial fibrillation: Predictors of late recurrence. J Thorac Cardiovasc Surg Jan. 2005;129:104–11. doi: 10.1016/j.jtcvs.2004.08.042. [DOI] [PubMed] [Google Scholar]
  • 3.Gillinov MA, Sirak J, Blackstone EH, McCarthy P, Rajeswaran J, Pettersson G. The Cox maze procedure in mitral valve disease: Predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:1653–60. doi: 10.1016/j.jtcvs.2005.07.028. [DOI] [PubMed] [Google Scholar]
  • 4.Damiano RJ, Jr., Schwartz FH, Bailey MS, Maniar H, Munfakh NA, Moon MR, et al. The Cox maze IV procedure: Predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141:113–121. doi: 10.1016/j.jtcvs.2010.08.067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Romano MA, Bach DS, Pagani FD, Prager RL, Deeb M, Bolling SF. Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery. Ann Thorac Surg. 2004;77:1282–87. doi: 10.1016/j.athoracsur.2003.06.022. [DOI] [PubMed] [Google Scholar]

Articles from Interactive Cardiovascular and Thoracic Surgery are provided here courtesy of Oxford University Press

RESOURCES